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The association between microbial landscapes (micro-
biome) and various immunopathological states with
postinfectious clinical-and-immunological syndrome
(PICIS) can be correlative or causal. In patients with
chronically relapsing infectious diseases (CRID), syndro-
mal forms of the immune-mediated disorders depend
crucially on the stage of the inflammatory process occur-
ring in the targeted organs or tissues and the overall
chronization of the disease.
For example, early stages of CRID are concomitant
with postinfectious secondary immunodeficiency syn-
drome (PIFSI) (› 50%), whereas the incidence and thus
the contribution of postinfectious autoimmune syn-
drome (PIFA) and autoimmune syndrome associated
with postinfectious secondary immunodeficiency (PIFA-
SID) do not exceed 20%. At the subsequent stages, the
clinical manifestations are different, viz., the incidence
and thus the contribution of the autoimmunity rises
dramatically (to 50% at the intermediate stages (PIFA)
and to 60% at the final stage (PIFASID).
The correlation between the stage of CRID and the
form of PICIS is also characterized by the involvement of
an additional (the third) component, viz., a clinical form
of CRID. Here are several analytical examples related to:
(1) clinical form of CRID: in patients with primary
pyelonephritis (PPNP) and infectious myocarditis (IM),
PIFSI is detected in 75% of clinical cases, whereas in
patients with secondary pyelonephrites (SPNP) and
autoimmune myocardites (AIM) the contribution of
PIFSI is notably reduced (to 25%) giving way to the
autoaggression (the incidence and thus the contribution
of PIFA and PIFASID increases to 60% and 85%,
respectively);
(2) stage of CRID: at the early (including preclinical
ones) stages (< 3 months for CPN and < 1 month for myo-
carditis (M)), PIFSI is detected in 40% of cases; however, at
the advanced stages of CRID its incidence reduced appre-
ciably, while that of autoimmune syndromes increases in
contrast;
(3) rate of progression and chronization of CRID:
in patients with relapsing or rapidly progressing CRID
(e.g., ICIIP or AIM), the incidence and thus the contribu-
tion of PIFSI do not exceed 32-36%, while the share
of autoimmune syndromes reaches 80-100%. In such
patients, persistent forms of chronic meningoencephalitis
(e.g., ICIIP) or AIM associated with myocardial dystro-
phies are predominant.
These findings suggest that PIFSI is not only the out-
come of the infectious process, but also the predictive sign
to promote chronization of the disease and to represent a
factor responsible for getting the clinical course chronic.
Further progression and chronization of CRID are con-
trolled by postinfectious autoaggression factors, such as
PIFA and PIFASID which are thus also considered as pre-
dictive factors to monitor transformation of subclinical
forms into the clinical ones.
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